World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
114
Citations
38497
World Ranking
4805
National Ranking
2609

Overview

Philip B. Paty is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research primarily focuses on Medicine, with an emphasis on Oncology, Surgery, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, and Cancer Research.

The main topics of their work include colorectal cancer surgical treatments, colorectal and anal carcinomas, genetic factors in colorectal cancer, colorectal cancer treatments and studies, colorectal cancer screening and detection, gastric cancer management and outcomes, and radiomics and machine learning in medical imaging.

Philip B. Paty has contributed to numerous publications in various journals. Frequent publication venues for their research include:

  • Journal of Clinical Oncology
  • Annals of Surgical Oncology
  • Diseases of the Colon & Rectum
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Cancer Research

Their recent papers cover several significant topics in colorectal cancer treatment and research:

  • Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy, 2022, Journal of Clinical Oncology
  • Mismatch Repair-Deficient Rectal Cancer and Resistance to Neoadjuvant Chemotherapy, 2020, Clinical Cancer Research
  • Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial, 2023, Journal of Clinical Oncology
  • Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer, 2022, Nature Medicine
  • Patient-Reported Bowel Function in Patients With Rectal Cancer Managed by a Watch-and-Wait Strategy After Neoadjuvant Therapy: A Case-Control Study, 2020, Diseases of the Colon & Rectum

Frequent collaborators in their research include Julio García-Aguilar, Martin R. Weiser, J. Joshua Smith, Garrett M. Nash, and Emmanouil P. Pappou. Paty's collaboration network shows a concentrated involvement with researchers specialized in colorectal cancer and surgical oncology.

Best Publications

  • Wound Tissue Oxygen Tension Predicts the Risk of Wound Infection in Surgical Patients

    Harriet Williams Hopf;Thomas K. Hunt;Judith M. West;Peter Blomquist

  • Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis.

    Robert Martin;Philip Paty;Yuman Fong;Andrew Grace

  • Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.

    Andrea Cercek;Campbell S.D. Roxburgh;Campbell S.D. Roxburgh;Paul Strombom;J. Joshua Smith

  • Detecting Colorectal Cancer in Stool With the Use of Multiple Genetic Targets

    Seung Myung Dong;Giovanni Traverso;Constance M Johnson;Li Geng

  • Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer.

    Jose G. Guillem;David B. Chessin;Alfred M. Cohen;Jinru Shia

  • Neoadjuvant Chemotherapy Without Routine Use of Radiation Therapy for Patients With Locally Advanced Rectal Cancer: A Pilot Trial

    Deborah Schrag;Martin R. Weiser;Karyn A. Goodman;Mithat Gon̈en

  • Long-Term Results of Local Excision for Rectal Cancer

    Philip B. Paty;Garrett M. Nash;Paul Baron;Maureen Zakowski

  • Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy

    J. Joshua Smith;Paul Strombom;Oliver S. Chow;Campbell S. Roxburgh;Campbell S. Roxburgh

  • Nonoperative management of rectal cancer with complete clinical response after neoadjuvant therapy.

    James D. Smith;Jeannine A. Ruby;Karyn A. Goodman;Leonard B. Saltz

  • Neuroendocrine carcinomas of the colon and rectum.

    P. E. Bernick;D. S. Klimstra;J. Shia;B. Minsky

  • Somatic mutations of the Parkinson's disease–associated gene PARK2 in glioblastoma and other human malignancies

    Selvaraju Veeriah;Barry S Taylor;Shasha Meng;Fang Fang

  • Association of survival and disease progression with chromosomal instability: A genomic exploration of colorectal cancer

    Michal Sheffer;Manny D. Bacolod;Or Zuk;Sarah F. Giardina

  • Extracellular metabolic energetics can promote cancer progression.

    Jia Min Loo;Alexis Scherl;Alexander Nguyen;Fung Ying Man

  • A rectal cancer organoid platform to study individual responses to chemoradiation.

    Karuna Ganesh;Chao Wu;Kevin P. O’Rourke;Bryan C. Szeglin

  • Safety and efficacy of low anterior resection for rectal cancer: 681 consecutive cases from a specialty service.

    Warren E. Enker;Nipun Merchant;Alfred M. Cohen;Nicole M. Lanouette

  • Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management

    J. Joshua Smith;Oliver S. Chow;Marc J. Gollub;Garrett M. Nash

  • Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients.

    Leyo Ruo;Christina Gougoutas;Philip B Paty;Jose G Guillem

  • Conversion to Resectability Using Hepatic Artery Infusion Plus Systemic Chemotherapy for the Treatment of Unresectable Liver Metastases From Colorectal Carcinoma

    Nancy E. Kemeny;Fidel D. Huitzil Melendez;Marinela Capanu;Philip B. Paty

  • Mitochondrial Proliferation and Paradoxical Membrane Depolarization during Terminal Differentiation and Apoptosis in a Human Colon Carcinoma Cell Line

    Mariangela Mancini;Benjamin O. Anderson;Elizabeth Caldwell;Monireh Sedghinasab

  • Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy

    Leyo Ruo;Satish Tickoo;David S. Klimstra;Bruce D. Minsky

Frequent Co-Authors

Jose G. Guillem
Jose G. Guillem University of North Carolina at Chapel Hill
Martin R. Weiser
Martin R. Weiser Memorial Sloan Kettering Cancer Center
Jinru Shia
Jinru Shia Memorial Sloan Kettering Cancer Center
Leonard Saltz
Leonard Saltz Memorial Sloan Kettering Cancer Center
W. Douglas Wong
W. Douglas Wong Memorial Sloan Kettering Cancer Center
Bruce D. Minsky
Bruce D. Minsky The University of Texas MD Anderson Cancer Center
Julio Garcia-Aguilar
Julio Garcia-Aguilar Memorial Sloan Kettering Cancer Center
Alfred M. Cohen
Alfred M. Cohen Cancer Prevention Pharmaceuticals (United States)
J. Joshua Smith
J. Joshua Smith Memorial Sloan Kettering Cancer Center
Nancy E. Kemeny
Nancy E. Kemeny Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering studying medicine in the USA, it’s worth exploring related online degrees and career pathways. The healthcare field offers diverse options beyond becoming a physician, each with unique advantages and educational requirements.

For those interested in leadership roles, pursuing a Master of Healthcare Administration (MHA) is a popular option. Many students look for the cheapest mha programs online to balance affordability and quality. Comparing costs is essential, so understanding the cost of mha degree programs can help you make an informed decision.

Advanced practice nurses may benefit from the cheapest online dnp programs, allowing them to combine clinical expertise with leadership skills.

Pharmacists seeking career advancement also have options for distance learning. Earning an online pharmacist degree can create pathways in research, clinical practice, and administration.

Exploring these online degrees can open doors to specialized roles in healthcare, often with greater flexibility and accessibility than traditional routes.

Best Scientists Citing Philip B. Paty

Trending Scientists